Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam vs Dexmedetomidine for Sedation in Urologic Surgery with OSA Risk
NCT04817033Phase 4Completed
- Sponsor
- Clinical Hospital Center Split
- Start
- Apr 2021
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine in bladder neoplasms (BCa), benign prostatic hyperplasia (BPH), sponsored by Clinical Hospital Center Split. Started Apr 2021; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
bladder neoplasms (BCa)benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT04817033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04817033.